I keep hearing quotes like this on this forum, but this is not accurate. We might pay money for hair cloning, but most people won't. The market for hair cloning technology is dwarfed by the markets for cloning technology in areas such as cancer treatment and the like. Hair treatments are such a small market compared to other markets that drug companies aren't even willing to invest the $$ in testing, seeking FDA approval and marketing better hair loss medications. Propecia was not a huge money-maker, and so drug companies are not investing in additional products, even though it's now well-known how to make a 5ar inhibitor that doesn't infringe Merck's patent.